GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Talphera Inc (FRA:R5XA) » Definitions » Cyclically Adjusted PS Ratio

Talphera (FRA:R5XA) Cyclically Adjusted PS Ratio : (As of Jun. 24, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Talphera Cyclically Adjusted PS Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Talphera Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Talphera's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Talphera Cyclically Adjusted PS Ratio Chart

Talphera Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.45 5.30 - - 0.20

Talphera Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.19 0.10 0.20 -

Competitive Comparison of Talphera's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, Talphera's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Talphera's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Talphera's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Talphera's Cyclically Adjusted PS Ratio falls into.



Talphera Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Talphera's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Talphera's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=0/131.7762*131.7762
=0.000

Current CPI (Mar. 2024) = 131.7762.

Talphera Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 0.023 100.560 0.030
201409 1.692 100.428 2.220
201412 0.082 99.070 0.109
201503 0.075 99.621 0.099
201506 0.773 100.684 1.012
201509 6.104 100.392 8.012
201512 0.711 99.792 0.939
201603 1.199 100.470 1.573
201606 1.780 101.688 2.307
201609 1.323 101.861 1.712
201612 2.691 101.863 3.481
201703 1.282 102.862 1.642
201706 1.043 103.349 1.330
201709 0.538 104.136 0.681
201712 0.248 104.011 0.314
201803 0.109 105.290 0.136
201806 0.270 106.317 0.335
201809 0.108 106.507 0.134
201812 0.152 105.998 0.189
201903 0.060 107.251 0.074
201906 0.211 108.070 0.257
201909 0.139 108.329 0.169
201912 0.108 108.420 0.131
202003 0.087 108.902 0.105
202006 0.644 108.767 0.780
202009 0.264 109.815 0.317
202012 0.131 109.897 0.157
202103 0.076 111.754 0.090
202106 0.062 114.631 0.071
202109 0.266 115.734 0.303
202112 0.000 117.630 0.000
202203 0.000 121.301 0.000
202206 0.000 125.017 0.000
202209 0.000 125.227 0.000
202212 0.000 125.222 0.000
202303 0.000 127.348 0.000
202306 0.021 128.729 0.021
202309 0.007 129.860 0.007
202312 0.014 129.419 0.014
202403 0.000 131.776 0.000

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Talphera  (FRA:R5XA) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Talphera Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Talphera's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Talphera (FRA:R5XA) Business Description

Traded in Other Exchanges
Address
25821 Industrial Boulevard, Suite 400, Hayward, CA, USA, 94545
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of innovative therapies for use in medically supervised settings. Its product portfolio includes Niyad that is a lyophilized formulation of nafamostat. It is also developing two pre-filled syringes, a pre-filled ephedrine syringe, and PFS-02, a pre-filled phenylephrine syringe.

Talphera (FRA:R5XA) Headlines

No Headlines